Listed by the USPTO as CLARK, AMY LYNN
Tech Center 1600 • Art Units: 1600 1628 1655 1699
This examiner grants 39% of resolved cases
Amy Lynn Clark serves in Tech Center 1600 and Art Unit 1600, having overseen 927 resolved cases. Her allowance rate pct is 39.2%. She has an interview lift pct of 31.1%, which suggests that applicants should consider an interview to improve their chances of success.
The median days to allowance for this examiner is 1491. Her docket is focused on companies like Novartis AG, Merck Patent GmbH, and AbbVie Inc. The firms MCCARTER & ENGLISH, LLP BOSTON, ARENTFOX SCHIFF LLP, and Blank Rome LLP are frequently active. The 1491-day median pendency is a factor to consider alongside the 39.2% allowance rate and 31.1% interview lift pct.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18291529 | SRPK INHIBITORS | Non-Final OA | Merck Patent GmbH |
| 18575739 | METHODS AND COMPOSITIONS FOR TREATMENT OF COVID-19 | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy39.2% of resolved applications examined by Amy Lynn Clark were allowed (927 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +31.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Amy Lynn Clark took 1,491 days on average from filing to allowance.
Amy Lynn Clark examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
